Formulation and characterization of nanostructured lipid carrier of ubiquinone (Coenzyme Q10)

Journal of Biomedical Nanotechnology

Volumn 9, Issue 3, 2013, Pages 450-460

  Nanjwade, Basavaraj K ^a   Kadam, Vikrant T ^a   Manvi, F V ^b  

^a India   (India)

^b K L E S S COLLEGE OF PHARMACY   (India)

Author keywords

Alzheimer's Disease; Anti Lipid Peroxidation; Antioxidant; Coenzyme Q10; DPPH Scavenging Activity; Locomotor Activity; Nanostructured Lipid Carrier; Parkinson's Disease; Precirol ATO 5; Ubiquinone

Indexed keywords

ALZHEIMER'S DISEASE; COENZYME Q10; LOCOMOTOR ACTIVITY; NANOSTRUCTURED LIPID CARRIERS; PARKINSON'S DISEASE; PEROXIDATION; PRECIROL ATO 5; SCAVENGING ACTIVITIES; UBIQUINONE;

ANTIOXIDANTS; ENCAPSULATION; FREE RADICALS; LIPIDS; LOADING; NANOPARTICLES; NEURODEGENERATIVE DISEASES; OXIDATIVE STRESS; PLANTS (BOTANY);

LIQUIDS;

1,1 DIPHENYL 2 PICRYLHYDRAZYL; GLYCEROL BEHENATE; GLYCEROL PALMITOSTEARATE; SCOPOLAMINE; SOLID LIPID NANOPARTICLE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRIACETIN; UBIDECARENONE;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; ENZYME ACTIVITY; FEMALE; IN VIVO STUDY; LIPID PEROXIDATION; LOCOMOTION; MALE; MAXIMUM PLASMA CONCENTRATION; NANOENCAPSULATION; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PARTICLE SIZE; RAT; TIME TO MAXIMUM PLASMA CONCENTRATION; ZETA POTENTIAL;

ANIMALS; ANTIOXIDANTS; BIPHENYL COMPOUNDS; CALORIMETRY, DIFFERENTIAL SCANNING; CHEMISTRY, PHARMACEUTICAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG CARRIERS; FEMALE; FREE RADICAL SCAVENGERS; KINETICS; LIPID PEROXIDATION; LIPIDS; MALE; MOTOR ACTIVITY; NANOSTRUCTURES; PARTICLE SIZE; PICRATES; RATS; RATS, WISTAR; SPECTROPHOTOMETRY, INFRARED; STATIC ELECTRICITY; TEMPERATURE; TIME FACTORS; UBIQUINONE;

EID: 84876592014     PISSN: 15507033     EISSN: 15507041     Source Type: Journal    
DOI: 10.1166/jbn.2013.1560     Document Type: Article

References (30)

1. T. Eldem, P. Speiser, and A. Hincal, Optimization of spray-dried and congealed lipid micropellets and characterization of their surface morphology by scanning electron microscopy. Pharm. Res. 8, 47 (1991).
2. P. Speiser, Lipidnanopelletsals Tragersystemfur Arzneimittelzurperoralen Anwendung, E. P. Patent 0167825, Janurary (1986).
3. R. H. Muller and J. S. Lucks, Arzneistofftrager aus festen Lipidteilchen, Feste Lipidnanospharen (SLN), E. P. Patent 0605497, July (1994).
4. M. R. Gasco, Method for producing solid lipid microspheres having a narrow size distribution. U.S. Patent 5,250,236, October (1993).
5. R. H. Muller, M. Radtke, and S. A. Wissing, Nanostructured lipid matrices for improved microencapsulation of drugs. Int. J. Pharm. 242, 121 (2002).
6. V. Jenning, A. F. Thunemann, and S. H. Gohla, Characterisation of a novel solid lipid nanoparticle carrier system based on binary mixtures of liquid and solid lipids. Int. J. Pharm. 199, 167 (2000).
7. V. Jenning and S. H. Gohla, Encapsulation of retinoids in solid lipid nanoparticles (SLN). J. Microencapsul. 18, 149 (2001).
8. K. Jores, W. Mehnert, and M. Drechsler, Investigations on the structure of solid lipid nanoparticles (SLN) and oil-loaded solid lipid nanoparticles by photon correlation spectroscopy, field-flow fractionation and transmission electron microscopy. J. Control Release 95, 217 (2004).
9. F. Castelli, C. Puglia, M. G. Sarpietro, L. Rizza, and F. Bonina, Characterization of indomethacin-loaded lipid nanoparticles by differential scanning calorimetry. Int. J. Pharm. 304, 231 (2005).
10. V. Jenning, K. Mäder, and S. H. Gohla, Solid lipid nanoparticles (SLNTM) based on binary mixtures of liquid and solid lipids: A 1H NMR study. Int. J. Pharm. 205, 15 (2000).
11. G. P. Littarru, Energy and defense: Facts and perspectives on coenzyme Q10 in biology and medicine, Casa Editrice Scientifica Internazionale (1994), pp. 1-91.
12. A. Arroyo, F. Navarro, C. Gomez-Diaz, F. L. Crane, F. J. Alcain, P. Navas, and J. M. Villalba, Interactions between ascorbyl free radical and coenzyme Q at the plazma membrane. J. Bioenerg. Biomembr. 32, 199 (2000).
13. B. Frei, M. Kim, and B. Ames, Ubiquinol-10 is an effective lipidsoluble antioxidant at physiological concentrations. Proc. Nati. Acad. Sci. USA 87, 4879 (1990).
14. Z. H. Wang, Z. Y. Wang, C. S. Sun, C. Y. Wang, T. Y. Jiang, and S. L. Wang, Trimethylated chitosan-conjugated PLGA nanoparticles for the dilvery of drugs to brain. Biomaterials 31, 908 (2010).
15. V. Teeranachaideekul and E. B. Souto, Cetyl palmitate based NLC for topical delivery of Coenzyme Q10 - Development, physical characterization and in vitro release studies. Eur. J. Pham. Biopharm. 67, 141 (2007).
16. J. Pardeike, K. Schwabe, and R. H. Muller, Influence of nanostructured lipid carriers (NLC) on the physical properties of the Cutanova Nanorepair Q10 cream and the in vivo skin hydration effect. Int. J. Pharm. 396, 166 (2010).
17. F. Q. Hu, S. P. Jiang, and Y. Z. Du, Preparation and characterization of stearic acid nanostructured lipid carriers by solvent diffusion method in an aqueous system. Colloids Surf. B Biointerfaces 45, 167 (2005).
18. K. L. Chan and S. G. Kazarian, Detection of trace materials with Fourier transform infrared spectroscopy using a multi-channel detector. Analyst 131, 126 (2006).
19. J. H. Flynn, Analysis of DSC results by integration. Thermochemica Acta 217, 129 (1993).
20. International Organisation for Standardisation (ISO), International Standard ISO13321: Methods for Determination of Particle Size Distribution Part 8: Photon Correlation Spectroscopy, (1996).
21. J. Pardeike, S. Weber, T. Heber, J. Wagner, H. P. Zarfl, H. Plank, and A. Zimmer, Development of an Itraconazole-loaded nanostructured lipid carrier (NLC) formulation for pulmonary application. Int. J. Pharm. 419, 329 (2011).
22. A. Saupe and K. C. Gordon, Structural investigations on nanoemulsions, solid lipid nanoparticles and nanostructuredlipidcarriers by cryo-field emission scanning electronmicroscopy and Raman spectroscopy. Int. J. Pharm. 14, 6 (2006).
23. Pankaj Pathak and Mangal Nagarsenker, Formulation and evaluation of lidocaine lipid nanosystems for dermal delivery. AAPS Pharm. Sci. Tech. 10, 985 (2009).
24. K. Mahendra, Y. L. N. Murthy, C. V. Narasimha Rao, and K. Bala Murali Krishna, Determination of Ubiquinone Q10 (Coenzyme Q10) and its synthesis related impurities by high performance liquid chromatography (HPLC) and mass spectrometry (MS). International Journal of Pharm. Tech. Research 3, 1467 (2011).
25. S. D. Mandawgade, S. Sharma, S. Pathak, and V. B. Patravale, Development of SMEDDS using natural lipophile: Application to beta Artemether delivery. Int. J. Pharm. 362, 179 (2008).
26. Pushpendra Jain, Mishra Amit, S. K. Yadav, U. K. Patil, and U. S. Baghel, Formulation development and characterization of solid lipid nanoparticles containing nimesulide. International Journal of Drug Delivery Technology 1, 24 (2009).
27. K. N. Chidambara Murthy, R. P. Singh, and G. K. Jayaprakasha, Antioxidant activates of Grape (Vitis vinifera) Pomace extracts. J. Agri. Food Chem. 50, 5909 (2002).
28. V. B. Junyaprasert, V. Teeranachaideekul, E. B. Souto, P. Boonme, and R. H. Muller, Q10-loaded NLC versus nanoemulsions: Stability, rheology and in vitro skin permeation. Int. J. Pharm. 377, 207 (2009).
29. C. M. Sena, E. Nunes, A. Gomes, M. S. Santos, T. Proenca, M. I. Martins, and R. M. Seica, Supplementation of coenzyme Q10 and alpha-tocopherol lowers glycated hemoglobin level and lipid peroxidation in pancreas of diabetic rats. Nutr. Res. 28, 113 (2008).
30. D. S. Sinatra, S. T. Sinatra, and C. J. Heyser, The effects of Coenzyme Q10 on locomotor and behavioral activity in young and aged C57BL/6 mice. Biofactors 18, 283 (2003).